Bridger Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-146,800
| Closed | -$4.93M | – | 33 |
|
|
2025
Q1 | $4.93M | Hold |
146,800
| – | – | 2.45% | 18 |
|
|
2024
Q4 | $5.75M | Hold |
146,800
| – | – | 3.09% | 12 |
|
|
2024
Q3 | $5.78M | Hold |
146,800
| – | – | 2.89% | 16 |
|
|
2024
Q2 | $5.72M | Hold |
146,800
| – | – | 2.95% | 13 |
|
|
2024
Q1 | $6.32M | Hold |
146,800
| – | – | 2.85% | 14 |
|
|
2023
Q4 | $6.76M | Buy |
+146,800
| New | +$6.76M | 2.59% | 15 |
|
|
2022
Q4 | – | Sell |
-45,235
| Closed | -$1.63M | – | 40 |
|
|
2022
Q3 | $1.63M | Sell |
45,235
-32,165
| -42% | -$1.16M | 0.49% | 33 |
|
|
2022
Q2 | $2.36M | Buy |
+77,400
| New | +$2.36M | 0.53% | 30 |
|